Behaviorally active doses of the CB 1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover

Author: Darmani N.A.   Janoyan J.J.   Kumar N.   Crim J.L.  

Publisher: Elsevier

ISSN: 0091-3057

Source: Pharmacology Biochemistry and Behavior, Vol.75, Iss.4, 2003-07, pp. : 777-787

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract